Metformin’s Multifaceted Benefits in Pregnancy and Longevity – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Metformin is emerging as a true ‘aspirin of the 21st century’. Originally a type 2 diabetes drug, it now sits at the crossroads of gestational diabetes care, preeclampsia prevention, oncology, and healthy ageing.
Mechanistically, metformin inhibits mitochondrial complex I, activates AMPK, and suppresses mTOR, leading to reduced insulin resistance, lower glucose output, dampened inflammation, and decreased angiogenesis (e.g., VEGF signalling). These pathways are central not only to metabolic disease but also to placental dysfunction and tumor biology.
Clinically, meta-analyses indicate that in gestational diabetes, metformin provides glycemic control comparable to insulin, often with less gestational weight gain and fewer neonatal hypoglycemia or macrosomia events. A key RCT in obese pregnancy did not reduce large-for-gestational-age infants (primary outcome) but did reduce preeclampsia rates, suggesting vascular benefits beyond glucose control.
Observational cohorts link metformin use to lower cancer incidence and improved survival, and ageing studies connect it to improved longevity markers, though definitive randomized evidence is still in progress.
For clinicians, researchers, and policymakers, the question is shifting from ‘Does metformin only treat diabetes?; to ‘Where else should we be using it—cautiously and strategically?’
How are you currently integrating metformin into pregnancy, oncology, or cardiometabolic pathways in your practice or research? Let’s discuss!
Metformin, Diabetes Care, Oncology, Healthy Aging, Gestational Diabetes, Preeclampsia, Research Discussion
Romero R. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology. 2017;217(3):282–302
Fertility Plus
92 Harley Street, London
Tel: 0800 022 6038
Email: [email protected]
Website: www.fertilityplus.org.uk”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE
-
Apr 30, 2026, 10:42The Link Between Lifestyle and Anti-Müllerian Hormone – RBMO